Surgery Partners (NASDAQ:SGRY) Announces Earnings Results, Misses Estimates By $0.06 EPS

Surgery Partners (NASDAQ:SGRY) issued its quarterly earnings data on Monday. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06), Briefing.com reports. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The firm had revenue of $821.50 million for the quarter, compared to analyst estimates of $823.55 million. During the same period in the prior year, the firm posted $0.19 earnings per share. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. Surgery Partners updated its FY 2025 guidance to EPS.

Surgery Partners Stock Down 24.0%

Surgery Partners stock traded down $5.16 during mid-day trading on Monday, hitting $16.34. The company’s stock had a trading volume of 3,918,663 shares, compared to its average volume of 1,372,712. Surgery Partners has a 52-week low of $16.31 and a 52-week high of $31.89. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78. The company has a market cap of $2.09 billion, a PE ratio of -11.42 and a beta of 1.85. The firm’s 50 day moving average is $21.62 and its 200 day moving average is $22.18.

Insider Activity at Surgery Partners

In other news, insider Harrison R. Bane sold 9,339 shares of the stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $22.48, for a total transaction of $209,940.72. Following the transaction, the insider owned 117,181 shares of the company’s stock, valued at approximately $2,634,228.88. This represents a 7.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.70% of the stock is currently owned by company insiders.

Institutional Trading of Surgery Partners

Several institutional investors have recently modified their holdings of SGRY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Surgery Partners by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 45,693 shares of the company’s stock valued at $1,085,000 after acquiring an additional 2,015 shares during the period. Millennium Management LLC lifted its holdings in shares of Surgery Partners by 1,253.7% during the first quarter. Millennium Management LLC now owns 202,274 shares of the company’s stock valued at $4,804,000 after acquiring an additional 219,806 shares during the period. Empowered Funds LLC grew its holdings in shares of Surgery Partners by 11.0% in the 1st quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock worth $305,000 after purchasing an additional 1,278 shares during the last quarter. Prudential Financial Inc. bought a new position in Surgery Partners in the 2nd quarter valued at $219,000. Finally, Invesco Ltd. increased its stake in shares of Surgery Partners by 7.4% in the second quarter. Invesco Ltd. now owns 1,683,311 shares of the company’s stock valued at $37,420,000 after buying an additional 115,627 shares in the last quarter.

Wall Street Analyst Weigh In

A number of research firms have recently commented on SGRY. JPMorgan Chase & Co. assumed coverage on shares of Surgery Partners in a research note on Thursday, September 18th. They set a “neutral” rating and a $27.00 price objective for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $36.00 price objective on shares of Surgery Partners in a research note on Tuesday, October 7th. Bank of America began coverage on Surgery Partners in a report on Monday, July 28th. They issued a “buy” rating and a $28.00 target price on the stock. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Surgery Partners in a research report on Wednesday, October 8th. Five research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $31.14.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.